2002
DOI: 10.1006/biol.2001.0290
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of a Quantitative Product-enhanced Reverse Transcriptase Assay to Monitor Retrovirus in mAb Cell-culture

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
16
0

Year Published

2002
2002
2014
2014

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 29 publications
(16 citation statements)
references
References 32 publications
0
16
0
Order By: Relevance
“…The PERT assay has been used as a method to quantify known and detect unknown retroviruses, with recognized limitations in terms of possible detection of RT-like activities of nonretroviral origin (Maudru & Peden 1997, André et al 2000, Brorson et al 2002.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…The PERT assay has been used as a method to quantify known and detect unknown retroviruses, with recognized limitations in terms of possible detection of RT-like activities of nonretroviral origin (Maudru & Peden 1997, André et al 2000, Brorson et al 2002.…”
Section: Discussionmentioning
confidence: 99%
“…At the level of the assay itself, there are some reagents that may produce RT-like activity such as Taq DNA polymerases or RNase inhibitors (Pyra et al 1994). At the level of the tested sample, there are some enzymes that may display RT-like activity such as host DNA polymerases, some other nuclear enzymes, and polymerase from mitochondria (Brorson et al 2002).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, the ES-DMA and plaque assay data did not yield the same counts (Table 7.1), which implied that not all phage particles were infectious such that a direct comparison to infectivity data led to a 10 to 40 fold disparity in the measured values, a common observation in virology when comparing the infectivity assay to methods that physically count particles [192,193]. This discrepancy between the plaque assay and the ES-DMA measured concentrations presumably involves several factors.…”
mentioning
confidence: 99%